HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Véronique Minard-Colin Selected Research

Vinorelbine (Navelbine)

10/2012Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Véronique Minard-Colin Research Topics

Disease

20Neoplasms (Cancer)
01/2022 - 08/2009
10Rhabdomyosarcoma
01/2022 - 10/2012
10Sarcoma (Soft Tissue Sarcoma)
01/2022 - 06/2011
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 01/2018
3Lymphoma (Lymphomas)
01/2021 - 09/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 09/2015
2Agammaglobulinemia (Hypogammaglobulinemia)
01/2020 - 01/2005
2Neuroblastoma
12/2019 - 12/2018
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
04/2005 - 11/2003
1Alveolar Rhabdomyosarcoma
11/2021
1Genetic Translocation (Chromosomal Translocation)
01/2021
1Residual Neoplasm
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Brain Neoplasms (Brain Tumor)
12/2020
1Febrile Neutropenia
01/2020
1Infections
01/2020
1Leukemia
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Second Primary Neoplasms (Neoplasms, Second)
01/2020
1Neuralgia (Stump Neuralgia)
12/2019
1Myofibromatosis
01/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2018
1Hodgkin Disease (Hodgkin's Disease)
12/2018
1Fibroma (Fibromatosis)
12/2017
1Aggressive Fibromatosis (Desmoid)
12/2017
1Embryonal Rhabdomyosarcoma
12/2017
1Burkitt Lymphoma (Burkitt's Lymphoma)
09/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2015
1Neoplasm Metastasis (Metastasis)
04/2015
1Plexiform Neurofibroma
06/2014
1Pain (Aches)
06/2014
1Chronic Pain
06/2014
1Neurofibroma
06/2014
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2011
1Encephalitis (Encephalitis, Rasmussen)
04/2005
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
01/2005
1WHIM syndrome
01/2005
1Autosomal Recessive 3 Severe Congenital Neutropenia
01/2005

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
01/2022 - 09/2015
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 10/2012
3Anaplastic Lymphoma KinaseIBA
01/2022 - 01/2021
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
2Vincristine (Oncovin)FDA LinkGeneric
01/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2021
2NivolumabIBA
01/2021 - 01/2018
2AntibodiesIBA
12/2019 - 12/2018
2Protein Isoforms (Isoforms)IBA
04/2015 - 06/2011
2LigandsIBA
06/2011 - 01/2005
2PerforinIBA
04/2005 - 11/2003
1Etoposide (VP 16)FDA LinkGeneric
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
1IfosfamideFDA LinkGeneric
01/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1Biological ProductsIBA
11/2021
1Irinotecan (Camptosar)FDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1ceritinibIBA
01/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2021
1DesminIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1MyogeninIBA
01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020
1GangliosidesIBA
12/2019
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2019
1blinatumomabIBA
12/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1Alkylating AgentsIBA
09/2015
1Methotrexate (Mexate)FDA LinkGeneric
09/2015
1AnthracyclinesIBA
09/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2015
1Analgesics (Analgesic Drugs)IBA
06/2014
1MTOR InhibitorsIBA
06/2014
1Sirolimus (Rapamycin)FDA Link
06/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2014
1TOR Serine-Threonine KinasesIBA
06/2014
1Vinorelbine (Navelbine)FDA LinkGeneric
10/2012
1Natural Killer Cell ReceptorsIBA
06/2011
1Tyrosine Kinase InhibitorsIBA
06/2011
1AntigensIBA
08/2009
1NF-kappa B (NF-kB)IBA
01/2005
1Interferon gamma ReceptorIBA
01/2005
1Chemokine ReceptorsIBA
01/2005
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2005
1Proteins (Proteins, Gene)FDA Link
01/2005
1NF-KappaB Inhibitor alphaIBA
01/2005
1STAT1 Transcription FactorIBA
01/2005

Therapy/Procedure

11Drug Therapy (Chemotherapy)
01/2022 - 09/2015
6Radiotherapy
01/2022 - 05/2013
6Brachytherapy
01/2022 - 05/2016
5Therapeutics
08/2021 - 09/2015
4Immunotherapy
12/2020 - 01/2018
3Conservative Treatment
07/2018 - 01/2017
2Neoadjuvant Therapy
01/2022 - 09/2015
2Induction Chemotherapy
01/2021 - 04/2015
2Investigational Therapies (Experimental Therapy)
01/2021 - 01/2021
1Fecal Microbiota Transplantation
01/2018
1Aftercare (After-Treatment)
07/2017
1Minimally Invasive Surgical Procedures
01/2015